Phenothiazine, Butyrophenone, and Other Psychotropic Medication Poisonings in Children and Adolescents

Objective: To describe the presentation, epidemiology, management, and outcome of phenothiazine and butyrophenone ingestions in children requiring hospitalization. Method: Retrospective case series in two pediatric hospitals. Results: Eighty-six cases were identified among 83 patients. The majority (69.7%) of ingestions occurred in children <6 years of age and there was no gender predominance. These ingestions were more common in African Americans (65.1%). They occurred more commonly in the patient's (64.0%) or a relative's (22.1%) home and haloperidol and thioridazine accounted for 58.1% of exposures. Depressed levels of consciousness and dystonia were the most common presenting signs, present in 90.7% and 51.2% of patients, respectively. Miosis occurred in only 13.9% of the patients. Fluid boluses were administered to 28.7% of the patients but about a quarter of these had coingested potentially cardiotoxic drugs. In addition, 2 of the 12 (13.9%) patients with abnormal electrocardiograms had also ingested potentially cardiotoxic drugs. Numerous diagnostic tests were performed in these patients including electrolyte panels (80.2%), complete blood counts (69.8%), liver function tests (31.4%), serum osmolality (20.9%), blood cultures (10.5%), lumbar punctures (17.4%), head computed tomographies (15.1%), and electroencephalograms (3.5%). The median length of hospitalization was 1.78 (range 1–9) days and there were no deaths. Patients presenting with dystonias were more likely to have extensive diagnostic testing for neurologic disease than those presenting without dystonias. Conclusion: The presentation of phenothiazine and butyrophenone ingestions in children and adolescents may be nonspecific and confounded by coingestants. Patients with dystonias had more extensive neurologic testing than patients without dystonias, suggesting that physicians may not recognize dystonias as a clinical finding characteristic of phenothiazine or butyrophenone exposure.

[1]  T. Litovitz,et al.  1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2000, The American journal of emergency medicine.

[2]  T. Litovitz,et al.  1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1998, The American journal of emergency medicine.

[3]  S. R. Rose,et al.  2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2003, The American journal of emergency medicine.

[4]  F. Jiménez-Jiménez,et al.  Drug-Induced Movement Disorders , 1997, Drug safety.

[5]  H. Hennes,et al.  Upper airway compromise in acute chlorpromazine ingestion. , 1996, The American journal of emergency medicine.

[6]  T. Matsuishi,et al.  Acute accidental overdosage of haloperidol in children , 1993, Acta paediatrica.

[7]  P. Krupp,et al.  Acute overdosage with thioridazine: a review of the available clinical exposure. , 1993, Veterinary and human toxicology.

[8]  J. Blumer,et al.  Phenothiazine-Associated Apnea in Two Siblings , 1991, DICP : the annals of pharmacotherapy.

[9]  G. Schumock,et al.  Acute oculogyric crisis after administration of prochlorperazine. , 1991, Southern medical journal.

[10]  R. Roberts,et al.  Phenothiazine and butyrophenone intoxication in children. , 1986, Pediatric clinics of North America.

[11]  J. Blumer,et al.  Accidental chlorpromazine ingestion as a cause of neuroleptic malignant syndrome in children. , 1985, The Journal of pediatrics.

[12]  A. Kahn,et al.  Phenothiazine-induced sleep apneas in normal infants. , 1985, Pediatrics.

[13]  P. Vlachos.  Dystonic reactions following thiethylperazine in children. , 1982, Toxicology letters.

[14]  A. Kahn,et al.  Phenothiazines and sudden infant death syndrome. , 1982, Pediatrics.

[15]  R. Haslam,et al.  Promethazine-induced acute dystonic reactions. , 1980, American journal of diseases of children.

[16]  M. Challapalli,et al.  Hypertension in acute haloperidol poisoning. , 1979, The Journal of pediatrics.

[17]  A. Kahn,et al.  POSSIBLE ROLE OF PHENOTHIAZINES IN SUDDEN INFANT DEATH , 1979, The Lancet.

[18]  D. Greydanus,et al.  Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: two case reports with a literature review. , 1979, The Journal of clinical psychiatry.

[19]  C. Papadatos,et al.  Acute haloperidol poisoning in children. , 1978, The Journal of pediatrics.

[20]  W. Thornton,et al.  Toxic reactions from a haloperidol overdose in two children. Thermal and cardiac manifestations. , 1978, JAMA.

[21]  A. Mitchell,et al.  Drug ingestions associated with miosis in comatose children. , 1976, The Journal of pediatrics.

[22]  F. Meyskens,et al.  Phenothiazine poisoning. A review of 48 cases. , 1973, California medicine.

[23]  I. Collins.  Acute phenothiazine intoxication in children. , 1971, The Medical journal of Australia.

[24]  J. Davis,et al.  Overdosage of psychotropic drugs: a review. II. Antidepressants and other psychotropic agents. , 1968, Diseases of the nervous system.

[25]  J. Davis,et al.  Overdosage of psychotropic drugs: a review. I. Major and minor tranquilizers. , 1968, Diseases of the nervous system.

[26]  F. Lovejoy,et al.  Acute phenothiazine toxicity in childhood: a five-year survey. , 1967, Pediatrics.

[27]  L. Hollister.  Overdoses of psychotherapeutic drugs , 1966, Clinical pharmacology and therapeutics.

[28]  A. Dugdale,et al.  Acute poisoning with chlorpromazine. , 1963, Lancet.

[29]  H. Cann,et al.  Accidental ingestion and overdosage involving psychopharmacologic drugs. , 1960, The New England journal of medicine.

[30]  E. Shaw,et al.  Phenothiazine tranquilizers as a cause of severe seizures. , 1959, Pediatrics.

[31]  G. Marrubini.  [Fatal chlorpromazine poisoning]. , 1959, Minerva medica.

[32]  H. Raybin,et al.  Briefs on accidental chemical poisonings in New York City. , 1958, New York state journal of medicine.